Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Much of the public conversation around drugs such as Wegovy and Ozempic focuses on weight loss results
Conventional treatments and their limitations Where peptides offer advantages Peptides occupy a unique space
Retatrutide is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, placing it in a distinct class from existing weight-management treatments such as semaglutide and tirzepatide
Antiproliferative activity of Pteleopsis suberosa leaf extract and its flavonoid components in human prostate carcinoma cells
Because retatrutide does not hold a marketing authorisation in the UK, it is unlawful to sell, supply, or advertise it as a medicinal product under the Human Medicines Regulations 2012 (HMR 2012)
US$ 24.59
US$ 29.43
US$ 24.08
US$ 21.20
US$ 22.31
US$ 20.42
